CD4^+^ T cells that lack the adaptor protein SAP are little help to B cells, according to Cannons and colleagues on page 1551. But their unhelpful nature does not result from a failure to produce T helper (Th)-2 cytokines, as the authors had previously thought.

Figure 1Wild-type CD4^+^ T cells (black circles), but not SAP-deficient CD4^+^ T cells (closed squares), restore antibody production in SAP-deficient mice.

The absence of SAP wreaks havoc on the immune system. SAP---the adaptor that links the SLAM family of activating receptors to the downstream signaling protein Fyn---is expressed in most immune cell types and its absence causes a bevy of immune defects.

Mutations in SAP cause a rare disease called X-linked lymphoproliferative disease (XLP), which is characterized in part by extreme susceptibility to Epstein Barr virus (EBV) infection. Those who survive EBV infection often have long-term antibody deficiencies. But Cannons and colleagues put the blame for this not on B cells, but on CD4^+^ T cells.

Previous studies in SAP-deficient mice revealed defects in both CD4^+^ T cells and B cells. But whether one cell type is mostly to blame for the glitch in antibody production has been controversial. Here, Cannons and colleagues put the rap squarely on the CD4^+^ T cells, as transfer of wild-type T cells into SAP-deficient mice restored immunization-induced antibody production, even when the B cells still lacked the adaptor.

The authors suspected (based on previous work with SAP-deficient T cells) that SAP-deficient mice might be unable to secrete antibody-promoting Th2 cytokines, such as interleukin (IL)-4 and IL-10. But when they infected the mice with *Shistosoma mansonii* eggs---a classic Th2 trigger---the mice had no problem producing these cytokines. Antibody production, on the other hand, was still blocked.

The antibody defect was instead traced to changes in the expression of two T cell costimulatory molecules: CD40 ligand (CD40L) and ICOS. In SAP-deficient cells, CD40L expression was increased and ICOS expression was decreased---both changes that have been shown to inhibit antibody production. An increase in ICOS expression has also been reported on T cells from patients with XLP.

SAP\'s ability to bind Fyn was dispensable for antibody production, as T cells containing a Fyn binding mutant of SAP still restored antibody production in mutant mice. The authors are now characterizing this previously unrecognized signaling pathway. ![](jem_iti_end.jpg)
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